Inari Medical Overview
Inari Medical Target Price
Analysts' 12-month price predictions for NARI.
Get informed when a big investor buys or sells
+ FollowShare Price
$79.97
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-12-18 | Truist FinancialRichard Newitter | $63 |  21.2% downside |  |
| 2024-10-29 | Robert W. BairdDavid Rescott | $67 | 16.2% downside | |
| 2024-10-29 | Piper SandlerAdam Maeder | $52 | 35% downside | |
| 2024-10-29 | Canaccord GenuityWilliam Plovanic | $74 | 7.5% downside | |
| 2024-10-29 | Truist FinancialRichard Newitter | $50 | 37.5% downside | |
| 2024-10-29 | BTIGMarie Thibault | $86 |  7.5% upside | |
| 2024-10-15 | Robert W. BairdDavid Rescott | $66 | 17.5% downside | |
| 2024-09-17 | Stifel NicolausMathew Blackman | $50 | 37.5% downside | |
| 2024-08-09 | Deutsche BankPito Chickering | $68 | 15% downside | |
| 2024-07-31 | Robert W. BairdDavid Rescott | $63 | 21.2% downside | |
| 2024-07-31 | Wells FargoLarry Biegelsen | $65 | 18.7% downside | |
| 2024-07-16 | Truist FinancialRichard Newitter | $60 | 25% downside | |
| 2024-05-01 | Piper SandlerAdam Maeder | $50 | 37.5% downside | |
| 2023-01-06 | Morgan Stanley | $83 | 3.8% upside | |
| 2022-12-20 | Truist Financial | $75 | 6.2% downside | |
| 2022-09-16 | Canaccord Genuity | $94 | 17.5% upside | |
| 2022-07-15 | Morgan Stanley | $93 | 16.3% upside | |
| 2022-06-24 | BTIG | $100 | 25% upside | |